Yooma Wellness Reports Results for Q4 and Fiscal 2021, Exceeding Forecasts with Revenue of US$5.3M in Q4 2021
Retrieved on:
Tuesday, May 17, 2022
N8, QVC, Mission statement, Holland & Barrett, Rationalization, Today's Special, Stock, YOOM, Financial statement, EBay, John Bell & Croyden, LLC, LloydsPharmacy, Amazon (company), Marketing, CSE, Nihon TV Hai, Vertex, Rakuten, Casino, Administration, Acquisition, Growth, Skin care, GLOBE, Company, Vitality, Efficiency, Pharmacist, Royal warrant, Royal Warrant of Appointment (United Kingdom), Fuji TV, Canadian Securities Exchange, SEDAR, Special, Greenleaf, Oil, Industry, Sale, Carrefour, Yahoo!, Pharmacy, CEO, Security (finance), Reinsurance, Retail, Animal, Online shopping, Dietary supplement, Flour, USD, Amazon, Hemp, Selfridges, CBD, ASDA
Lorne Abony, Chairman at Yooma commented We are delighted with the Q4 results, which position Yooma as one of the largest publicly-listed CBD wellness companies outside of North America.
Key Points:
- Lorne Abony, Chairman at Yooma commented We are delighted with the Q4 results, which position Yooma as one of the largest publicly-listed CBD wellness companies outside of North America.
- They also make it difficult to move to other regulated stock exchanges and raise the much-needed growth capital to support our brands.
- The Company will make a further announcement in due course regarding the results of its strategic review.
- Vitality CBD products continue to achieve premium rankings on Amazon UK for CBD search results and significant revenue growth.